Invesco Exchange-Traded Fund Trust II. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Private Prime FundCash or money market | 21.48% | $28.21M | 28,204,069 |
| Invesco Private Government FundCash or money market | 8.27% | $10.86M | 10,864,717 |
| Molina Healthcare, Inc.MOH | 4.77% | $6.26M | 36,074 |
| BrightSpring Health Services, Inc.BTSG | 4.35% | $5.72M | 92,724 |
| Krystal Biotech, Inc.KRYS | 4.25% | $5.59M | 18,078 |
| Alkermes PLC | 3.71% | $4.88M | 115,659 |
| Corcept Therapeutics Inc.CORT | 3.47% | $4.56M | 65,575 |
| Glaukos Corp.GKOS | 3.17% | $4.16M | 40,231 |
| PTC Therapeutics, Inc.PTCT | 3.16% | $4.15M | 56,239 |
| Protagonist Therapeutics, Inc.PTGX | 3.12% | $4.10M | 41,163 |
| Teleflex Inc.TFX | 3.03% | $3.98M | 30,957 |
| TG Therapeutics, Inc.TGTX | 2.75% | $3.61M | 95,238 |
| Ligand Pharmaceuticals Inc.LGND | 2.43% | $3.20M | 13,787 |
| Indivior Pharmaceuticals, Inc.INDV | 2.40% | $3.15M | 87,455 |
| RadNet, Inc.RDNT | 2.06% | $2.71M | 48,790 |
| Merit Medical Systems, Inc.MMSI | 1.99% | $2.62M | 41,530 |
| Veracyte, Inc.VCYT | 1.95% | $2.57M | 55,371 |
| Catalyst Pharmaceuticals, Inc. | 1.92% | $2.53M | 80,930 |
| Organon & Co.OGN | 1.85% | $2.43M | 182,108 |
| ICU Medical, Inc.ICUI | 1.78% | $2.34M | 17,293 |
| Integer Holdings Corp.ITGR | 1.67% | $2.19M | 24,543 |
| Concentra Group Holdings Parent, Inc.CON | 1.58% | $2.08M | 83,494 |
| Acadia Pharmaceuticals Inc.ACAD | 1.45% | $1.90M | 87,695 |
| Supernus Pharmaceuticals, Inc.SUPN | 1.41% | $1.85M | 40,164 |
| Privia Health Group, Inc.PRVA | 1.33% | $1.74M | 80,989 |
| Alignment Healthcare, Inc.ALHC | 1.31% | $1.72M | 112,187 |
| TransMedics Group, Inc.TMDX | 1.22% | $1.61M | 23,938 |
| National HealthCare Corp.NHC | 1.22% | $1.60M | 8,694 |
| Waystar Holding Corp.WAY | 1.22% | $1.60M | 80,407 |
| Prestige Consumer Healthcare Inc.PBH | 1.20% | $1.58M | 33,145 |
| Amneal Pharmaceuticals, Inc.AMRX | 1.19% | $1.57M | 118,907 |
| Arcus Biosciences, Inc.RCUS | 1.15% | $1.50M | 59,378 |
| Acadia Healthcare Co., Inc.ACHC | 1.14% | $1.50M | 64,623 |
| Progyny, Inc.PGNY | 1.09% | $1.44M | 56,161 |
| Omnicell, Inc.OMCL | 1.06% | $1.39M | 31,435 |
| LeMaitre Vascular, Inc.LMAT | 1.05% | $1.38M | 14,620 |
| Neogen Corp.NEOG | 1.04% | $1.37M | 152,368 |
| CorVel Corp.CRVL | 1.03% | $1.35M | 21,856 |
| ADMA Biologics, Inc.ADMA | 1.01% | $1.33M | 166,708 |
| Sarepta Therapeutics, Inc.SRPT | 1.00% | $1.31M | 73,400 |
| Select Medical Holdings Corp. | 0.97% | $1.27M | 77,190 |
| Pediatrix Medical Group, Inc.MD | 0.97% | $1.27M | 58,965 |
| LifeStance Health Group, Inc.LFST | 0.93% | $1.22M | 158,024 |
| UFP Technologies, Inc.UFPT | 0.90% | $1.19M | 5,401 |
| Vericel Corp.VCEL | 0.90% | $1.18M | 35,425 |
| Addus HomeCare Corp.ADUS | 0.89% | $1.17M | 12,775 |
| Astrana Health, Inc.ASTH | 0.87% | $1.14M | 30,220 |
| Innoviva, Inc.INVA | 0.81% | $1.07M | 49,754 |
| Perrigo Co. PLCPRGO | 0.81% | $1.07M | 96,401 |
| STAAR Surgical Co.STAA | 0.79% | $1.04M | 34,842 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.